GR1002332B - Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη. - Google Patents

Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.

Info

Publication number
GR1002332B
GR1002332B GR930100197A GR930100197A GR1002332B GR 1002332 B GR1002332 B GR 1002332B GR 930100197 A GR930100197 A GR 930100197A GR 930100197 A GR930100197 A GR 930100197A GR 1002332 B GR1002332 B GR 1002332B
Authority
GR
Greece
Prior art keywords
simethicone
novel
pharmaceutical compositions
containing pharmaceutical
loperamide
Prior art date
Application number
GR930100197A
Other languages
English (en)
Other versions
GR930100197A (el
Inventor
Edward J. Roche
Michael R. Hoy
Stevens A. Charles
Original Assignee
Mcneil-Ppc Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26715151&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR1002332(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil-Ppc Inc. filed Critical Mcneil-Ppc Inc.
Publication of GR930100197A publication Critical patent/GR930100197A/el
Publication of GR1002332B publication Critical patent/GR1002332B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
GR930100197A 1992-05-21 1993-05-17 Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη. GR1002332B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88720792A 1992-05-21 1992-05-21
US3839793A 1993-03-29 1993-03-29

Publications (2)

Publication Number Publication Date
GR930100197A GR930100197A (el) 1994-01-31
GR1002332B true GR1002332B (el) 1996-05-16

Family

ID=26715151

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930100197A GR1002332B (el) 1992-05-21 1993-05-17 Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.

Country Status (7)

Country Link
US (4) US5679376A (el)
EP (1) EP0571217B1 (el)
BR (1) BR1100507A (el)
CA (1) CA2096575C (el)
DE (1) DE69315257T2 (el)
ES (1) ES2112387T3 (el)
GR (1) GR1002332B (el)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177125B1 (en) * 1994-08-03 2001-01-23 Gunter M. Voss Method of producing coated tablets
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6800329B2 (en) * 1999-02-12 2004-10-05 Lts Lohmann Therapie-Systeme Ag Method for producing film-type dosage
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6100245A (en) * 1999-09-07 2000-08-08 Mcneil-Ppc, Inc. Use of simethicone to treat ulcerative colitis
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
EP1242057A2 (en) * 1999-11-02 2002-09-25 DepoMed, Inc. Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
DE60112756T2 (de) * 2000-06-23 2006-06-08 Bioprojet Racecadotril enthaltende trockene pulverformulierung
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6669271B2 (en) * 2001-06-22 2003-12-30 East Manufacturing Corporation Smooth side body structure and method
BR0206062A (pt) 2001-09-28 2004-01-13 Mcneil Ppc Inc Formas de dosagem tendo um núcleo interno e invólucro externo
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
US7378081B2 (en) * 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
US20050180920A1 (en) * 2003-01-29 2005-08-18 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7096533B2 (en) * 2004-06-12 2006-08-29 Kruegar International, Inc. Locking roller for an article of furniture
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
BRPI0621391A2 (pt) * 2006-03-09 2011-12-06 World Trade Imp Export Wtie Ag combinação sinérgica de inibidores de receptores h2, silicone inerte e um complexo de aluminato de hidroximagnésio
US7976872B2 (en) * 2006-07-24 2011-07-12 L. Perrigo Company Method for distributing a pharmaceutically active compound in an excipient
US7754041B2 (en) * 2006-07-31 2010-07-13 3M Innovative Properties Company Pleated filter with bimodal monolayer monocomponent media
US7662373B2 (en) * 2006-09-18 2010-02-16 Thompson Ronald J Method and composition of a medicament to decrease the adverse events of Olistat, an oral lipase inhibitor
WO2008056200A1 (en) * 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of simethicone
MX2011002515A (es) 2008-09-09 2011-04-07 Astrazeneca Ab Metodo de administracion de una composicion farmaceutica a un paciente que lo necesita.
MX2011013467A (es) 2009-06-25 2012-02-13 Astrazeneca Ab Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
MX2014007935A (es) 2011-12-28 2014-11-14 Pozen Inc Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
US20180311201A1 (en) 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics
WO2017106812A1 (en) 2015-12-19 2017-06-22 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
US10722472B2 (en) 2017-09-29 2020-07-28 Johnson & Johnson Consumer Inc. Solid simethicone particles and dosage form thereof
KR20200128079A (ko) * 2018-02-26 2020-11-11 알.피.쉐러 테크놀러지즈 엘엘씨 시메티콘 및 로페라미드의 에멀션을 위한 약제학적 제형
GR1009632B (el) * 2018-07-09 2019-10-25 Ιουλια Κλεωνος Τσετη Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος
WO2023089432A1 (en) * 2021-11-16 2023-05-25 Johnson & Johnson Consumer Inc. Customizable dosage forms containing simethicone
WO2023187225A1 (en) * 2022-04-01 2023-10-05 Amplicon Ab Alkaline intraoral products

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
NL7504704A (nl) * 1974-05-16 1975-11-18 Hoffmann La Roche Geneesmiddel.
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
CA1139221A (en) * 1978-10-10 1983-01-11 Vijay B. Surpuriya Antacid compositions
US4198390A (en) * 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
US4316888A (en) * 1980-04-15 1982-02-23 Nelson Research & Development Co. Method and composition of reducing pain
US4428927A (en) * 1981-05-11 1984-01-31 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4857324A (en) * 1985-10-08 1989-08-15 American Home Products Corporation (Del.) Exogenously acidified antacid compositions having cytoprotective properties
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
ATE73328T1 (de) * 1987-05-08 1992-03-15 Smith Kline French Lab Pharmazeutische zusammensetzungen.
US5275819A (en) * 1989-02-06 1994-01-04 Amer Particle Technologies Inc. Drug loaded pollen grains with an outer coating for pulsed delivery
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
IN171919B (el) * 1989-11-01 1993-02-06 Mcneil Ppc Inc
US5204118A (en) * 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5116847A (en) * 1991-01-25 1992-05-26 The Procter & Gamble Company Use of loperamide and related compounds for treatment of respiratory disease symptoms
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
US5447918A (en) * 1992-07-27 1995-09-05 Mccullough; Ricky W. Gastrointestinal anti-irritant composition comprising sucralfate and methods of use
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids

Also Published As

Publication number Publication date
GR930100197A (el) 1994-01-31
US5980944A (en) 1999-11-09
EP0571217A3 (en) 1994-06-01
US5716641A (en) 1998-02-10
CA2096575A1 (en) 1993-11-22
EP0571217A2 (en) 1993-11-24
DE69315257T2 (de) 1998-05-14
CA2096575C (en) 2003-05-13
US5599577A (en) 1997-02-04
US5679376A (en) 1997-10-21
ES2112387T3 (es) 1998-04-01
BR1100507A (pt) 2002-04-02
DE69315257D1 (de) 1998-01-02
EP0571217B1 (en) 1997-11-19

Similar Documents

Publication Publication Date Title
GR1002332B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
DK0600725T3 (da) Farmaceutiske præparater indeholdende en guanidinothiazolforbindelse og antacider
IT1201087B (it) Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
AU7848187A (en) Pharmaceutical formulations
CA2238271A1 (en) Pharmaceutical compositions comprising flurbiprofen
KR910009273A (ko) 위장관계 통증 치료용 약제학적 조성물
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
IL65328A (en) Pharmaceutical compositions comprising a calcium-antagonistic gallopamil or verapamil and their preparation
EP0166357A3 (en) Benzofused lactams and pharmaceutical compositions containing them
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
IL62197A (en) Imino-prostacyclines,their preparation and pharmaceutical compositions containing them
IT1213173B (it) Composti ad attivita'antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
IL91152A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
EP0351876A3 (en) Composition for potentiating vaccination effect
IT8219486A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8221678A0 (it) Esteri basici ad attivita'calcioantagonista, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
ES519605A0 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas.
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
EP0015721A1 (en) Composition for rheumatoid arthritis and other arthritic conditions and method for its preparation

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees